Latest Versant Venture Management, LLC Stock Portfolio
Versant Venture Management, LLC Performance:
2025 Q4: -19.35%YTD: -28.54%2024: -50.49%
Performance for 2025 Q4 is -19.35%, and YTD is -28.54%, and 2024 is -50.49%.
About Versant Venture Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-02-12, the fund reported it's updated stock portfolio. In the 13F Holdings report, Versant Venture Management, LLC reported an equity portfolio of $151.1 Millions as of 31 Dec, 2025.
The top stock holdings of Versant Venture Management, LLC are GLUE, , AVTE. The fund has invested 45.5% of it's portfolio in MONTE ROSA THERAPEUTICS, INC. and 28.1% of portfolio in LENZ THERAPEUTICS, INC. .
The fund managers got completely rid off REPARE THERAPEUTICS, INC. (RPTX) and ADVERUM BIOTECHNOLOGIES, INC. (ADVM) stocks. They significantly reduced their stock positions in MONTE ROSA THERAPEUTICS, INC. (GLUE).
The top stock holdings of Versant Venture Management, LLC are GLUE, , AVTE. The fund has invested 45.5% of it's portfolio in MONTE ROSA THERAPEUTICS, INC. and 28.1% of portfolio in LENZ THERAPEUTICS, INC. .
The fund managers got completely rid off REPARE THERAPEUTICS, INC. (RPTX) and ADVERUM BIOTECHNOLOGIES, INC. (ADVM) stocks. They significantly reduced their stock positions in MONTE ROSA THERAPEUTICS, INC. (GLUE).
Versant Venture Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Versant Venture Management, LLC made a return of -19.35% in the last quarter. In trailing 12 months, it's portfolio return was -28.54%.
- Performance
- S&P 500
New Buys
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| monte rosa therapeutics, inc. | -22.47 |
Versant Venture Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| repare therapeutics, inc. | -4,658,120 |
| adverum biotechnologies, inc. | -2,295,900 |
Versant Venture Management, LLC got rid off the above stocks
Sector Distribution
Versant Venture Management, LLC has about 66.8% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 66.8 |
| Others | 33.2 |
Market Cap. Distribution
Versant Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- UNALLOCATED
- MID-CAP
| Category | % |
|---|---|
| SMALL-CAP | 61.1 |
| UNALLOCATED | 33.2 |
| MID-CAP | 5.2 |
Stocks belong to which Index?
About 61.1% of the stocks held by Versant Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 61.1 |
| Others | 38.9 |
Versant Venture Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Versant Venture Management, LLC
Versant Venture Management, LLC has 7 stocks in it's portfolio. proved to be the most loss making stock for the portfolio. GLUE was the most profitable stock for Versant Venture Management, LLC last quarter.
Last Reported on: 12 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADVM | adverum biotechnologies, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTE | jade biosciences, inc. | 15.59 | 1,525,820 | 23,543,400 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 5.17 | 148,831 | 7,804,700 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics, inc. | 45.49 | 4,382,690 | 68,720,500 | reduced | -22.47 | ||
| RPTX | repare therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SKYE | skye bioscience, inc. | 1.00 | 2,007,700 | 1,505,180 | unchanged | 0.00 | ||
| TPST | tempest therapeutics, inc. | 0.51 | 269,772 | 774,246 | unchanged | 0.00 | ||
| lenz therapeutics, inc. | 28.14 | 2,656,890 | 42,510,200 | unchanged | 0.00 | |||
| contineum therapeutics, inc. | 4.11 | 542,628 | 6,202,240 | unchanged | 0.00 | |||